A novel method for detection of IFN-lambda 3 binding to cells for quantifying IFN-lambda receptor expression (Q38713082)

5 September 2017

A novel method for detection of IFN-lambda 3 binding to cells for quantifying IFN-lambda receptor expression (English)

1 reference

5 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

9

Michael Houghton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

4

Lesley Baldwin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Adrian Egli

7

object named as

Adrian Egli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Rakesh Bhat

5

object named as

Rakesh Bhat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Gillian E S Minty

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Adil Mohamed

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Michael Joyce

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

D Lorne J Tyrrell

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

5 March 2017

1 reference

Journal of Immunological Methods

5 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

445

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

15-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

Differential receptor subunit affinities of type I interferons govern differential signal activation.

31 May 2020

cites work

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Biological activity of interleukins-28 and -29: comparison with type I interferons

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

IL-28B is a key regulator of B- and T-cell vaccine responses against influenza

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Interferon lambda 4 expression is suppressed by the host during viral infection.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Receptor density is key to the alpha2/beta interferon differential activities.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29)

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Human interferon-lambda3 is a potent member of the type III interferon family.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

IL-29 and IFNα differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNγ receptor expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Binding and activity of all human alpha interferon subtypes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

IFN-λ-mediated IL-12 production in macrophages induces IFN-γ production in human NK cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

IFN-lambda determines the intestinal epithelial antiviral host defense

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

IFN-λ is able to augment TLR-mediated activation and subsequent function of primary human B cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JIM.2017.03.001

Identifiers

DOI

10.1016/J.JIM.2017.03.001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28274837%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference